Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pediatr Dermatol ; 38(2): 522-523, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33320359

RESUMEN

A 7-year-old girl presented with a hyperkeratotic scale on the plantar surface of her left foot. A microscopic potassium hydroxide examination was performed and negative. Reflectance confocal microscopy was performed showing fungal hyphae and an inflammatory infiltrate confirming a diagnosis of tinea pedis.


Asunto(s)
Tiña del Pie , Trichophyton , Niño , Femenino , Humanos , Microscopía Confocal , Tiña del Pie/diagnóstico
2.
Phys Rev Lett ; 124(3): 033604, 2020 Jan 24.
Artículo en Inglés | MEDLINE | ID: mdl-32031852

RESUMEN

We present a scheme, based on the delocalized heralded addition of a single photon, to entangle two or more distinct field modes, each containing arbitrary light states. A high degree of entanglement can in principle endure light states of macroscopic intensities and is expected to be particularly robust against losses. We experimentally establish and measure significant entanglement between two identical weak laser pulses containing up to 60 photons each.

5.
Phys Rev Lett ; 119(1): 013601, 2017 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-28731763

RESUMEN

Strong nonlinearity at the single photon level represents a crucial enabling tool for optical quantum technologies. Here we report on experimental implementation of a strong Kerr nonlinearity by measurement-induced quantum operations on weak quantum states of light. Our scheme coherently combines two sequences of single photon addition and subtraction to induce a nonlinear phase shift at the single photon level. We probe the induced nonlinearity with weak coherent states and characterize the output non-Gaussian states with quantum state tomography. The strong nonlinearity is clearly witnessed as a change of sign of specific off-diagonal density matrix elements in the Fock basis.

7.
Phys Rev Lett ; 116(11): 110501, 2016 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-27035292

RESUMEN

We experimentally demonstrate a universal strategy for producing a quantum state that is orthogonal to an arbitrary, infinite-dimensional, pure input one, even if only a limited amount of information about the latter is available. Arbitrary coherent superpositions of the two mutually orthogonal states are then produced by a simple change in the experimental parameters. We use input coherent states of light to illustrate two variations of the method. However, we show that the scheme works equally well for arbitrary input fields and constitutes a universal procedure, which may thus prove a useful building block for quantum state engineering and quantum information processing with continuous-variable qubits.

9.
Echocardiography ; 32(12): 1841-50, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26053260

RESUMEN

INTRODUCTION: Current guidelines recommend three-dimensional echocardiography (3DE) as the reference technique to assess left ventricular (LV) volumes and ejection fraction (EF). We performed a meta-analysis to identify normative reference values by real time 3DE in healthy subjects. METHODS: We searched MEDLINE and the Cochrane Library databases using the key search terms three-dimensional echocardiography, volumes, and healthy. Data were pooled using random-effects meta-analysis, and source of variation was investigated using meta-regression. After selection, 13 articles were included (2806 subjects). Four studies were conducted in children and young adolescents; one study provided data in an independent pediatric subgroup. RESULTS: In adults, pooled mean value for LV EDV was 98.4 mL (95%CI, 87-110 mL), while LV ESV mean value was 37.0 mL (95%CI, 32-42 mL). LV EF mean value was 62.9% (95%CI 61.7-64.2%). Male subjects showed a significant increase in both LV EDV index (mean difference 5.3 mL/m(2) ; P < 0.001) and LV ESV index (mean difference 3.3 mL/m(2) ; P < 0.001). LV EF was significantly higher in female subjects (P = 0.003). In pediatric studies, LV EDV pooled mean value was 53.1 mL (95%CI, 38.1-68 mL), while for LV ESV, it was 19.8 mL (95%CI, 14.8-24.8 mL); LV EF mean value was 63.3% (95%CI, 61.6-65%). Significant heterogeneity and inconsistency were noted among studies. Age, systolic blood pressure, and heart rate were identified as a source of between-studies variation for LV volumes. Body surface area was a predictor of nonindexed LV volumes. CONCLUSIONS: Data from available studies of normative values for 3DE were summarized. Our findings may increase the generalizability of LV normative data by 3DE.


Asunto(s)
Envejecimiento/fisiología , Ecocardiografía Tridimensional/estadística & datos numéricos , Ecocardiografía Tridimensional/normas , Ventrículos Cardíacos/diagnóstico por imagen , Volumen Sistólico/fisiología , Función Ventricular Izquierda/fisiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Tamaño Corporal/fisiología , Sistemas de Computación , Femenino , Humanos , Interpretación de Imagen Asistida por Computador/normas , Masculino , Persona de Mediana Edad , Guías de Práctica Clínica como Asunto , Valores de Referencia , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Factores Sexuales , Adulto Joven
10.
Catheter Cardiovasc Interv ; 83(6): 1010-3, 2014 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-23982971

RESUMEN

Percutaneous transluminal angioplasty with or without stent has become the treatment of choice for stenotic lesion in subclavian arteries. However, there is a growing concern following many reports of stent fractures, a serious complication of endovascular therapy. We report for the first time a case of delayed left subclavian stent fracture with transection of the protruding ostial part and migration into the aortic carrefour that was retrieved by a snare device.


Asunto(s)
Angioplastia de Balón/efectos adversos , Angioplastia de Balón/instrumentación , Aorta , Arteriopatías Oclusivas/terapia , Remoción de Dispositivos , Migración de Cuerpo Extraño/terapia , Falla de Prótesis , Stents , Arteria Subclavia , Síndrome del Robo de la Subclavia/terapia , Anciano , Arteriopatías Oclusivas/diagnóstico , Constricción Patológica , Migración de Cuerpo Extraño/diagnóstico , Migración de Cuerpo Extraño/etiología , Humanos , Masculino , Diseño de Prótesis , Radiografía , Arteria Subclavia/diagnóstico por imagen , Síndrome del Robo de la Subclavia/diagnóstico , Resultado del Tratamiento
11.
Catheter Cardiovasc Interv ; 83(7): 1169-75, 2014 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-24323404

RESUMEN

BACKGROUND: Numerous reports have shown the relationship between carotid artery atherosclerosis and coronary artery disease (CAD). However, the association between complex CAD evaluated by SYNTAX score (SxScore) and prevalence of carotid lesion (CL) has not been fully investigated. We sought to assess the prevalence of carotid atherosclerosis in patients with multivessel CAD assessed by SxScore and the relationship between SxScore severity and features of carotid atherosclerosis. METHODS AND RESULTS: Subjects were 204 consecutive patients with multivessel CAD assessed by coronary angiography and no previous history of carotid atherosclerosis that underwent carotid ultrasound scan from June 2012 to 2013. Presence of CL, significant carotid disease (SCD) and carotid plaque morphology was evaluated. At least one CL was found in 159 patients (77.9%) with no significant difference among SxScore groups (P = 0.20 and P = 0.54, respectively). High prevalence of complex carotid plaque (CCP) was found without significant different distribution in SxScore groups (P = 0.69). Age was independently associated with the presence of CL [odds ratio (OR) 1.055; 95% confidence interval (CI): 1.015-1.097; P = 0.007] and SCD (OR 1.057; 95% CI: 1.008-1.097; P = 0.019). Age and diabetes were independently associated with CCP (OR 1.58; 95% CI: 1.023-1.095; P = 0.001; OR 1.848; 95% CI: 1.026-3.327; P = 0.041). SxScore was not independently associated with CL, SCD and CCP (all P > 0.2). CONCLUSIONS: We found high prevalence of CL in patients with multivessel complex CAD. However, SxScore does not seem to correlate with carotid atherosclerosis.


Asunto(s)
Enfermedades de las Arterias Carótidas/epidemiología , Enfermedad Coronaria/complicaciones , Enfermedades de las Arterias Carótidas/complicaciones , Enfermedades de las Arterias Carótidas/diagnóstico , Angiografía Coronaria , Enfermedad Coronaria/diagnóstico por imagen , Enfermedad Coronaria/epidemiología , Estudios de Seguimiento , Incidencia , Italia/epidemiología , Prevalencia , Pronóstico , Estudios Prospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Ultrasonografía Doppler en Color
12.
J Inherit Metab Dis ; 37(1): 109-16, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23615762

RESUMEN

AIMS: Fabry disease (FD) is a rare X-linked genetic disorder caused by the deficiency or absent activity of lysosomal α-galactosidase A. Cardiovascular remodelling is a hallmark of FD. The present study aimed to comprehensively evaluate the cardiac, vascular and microvascular status in a population of patients with genetic mutations for FD without left ventricular hypertrophy (LVH). METHODS AND RESULTS: This study includes subjects carrying genetic mutations for FD (Fabry disease mutation-carrier, FDMC) without LVH (n = 19). A group of control subjects (n = 19) matched for age, sex, body mass index and cardiovascular risk factors were also included. All subjects underwent echocardiography, carotid ultrasound scan, endothelial flow-mediated dilatation (FMD) and nailfold capillaroscopy (NFC) assessment. When compared to the subjects in the control group, FDMC patients showed significantly lower mean values of systolic myocardial velocity (7.33 ± 1.28 vs. 10.08 ± 1.63 cm/s, p < 0.0001), longitudinal systolic strain (-18.07 ± 1.72 vs. -21.15 ± 2.22%, p < 0.0001), significantly higher E/E' mean values (7.15 ± 1.54 vs. 5.98 ± 1.27, p = 0.016) and intima-media thickness mean values (0.80 ± 0.20 vs. 0.61 ± 0.19 mm, p = 0.005), significantly lower FMD (8.3 ± 4.6 vs. 12.2 ± 5.0%, p = 0.02), more atypical capillaries and irregular NFC architecture in FDMC than control subjects (52.6 vs. 0%, p < 0.0001; 78.9 vs. 36.8%, p = 0.02 respectively). CONCLUSIONS: FD progressively involves cardiac, macrovascular and microvascular systems in an early stage. These features are present even in asymptomatic mutation carriers without LVH.


Asunto(s)
Enfermedades Cardiovasculares/fisiopatología , Enfermedad de Fabry/genética , Enfermedad de Fabry/fisiopatología , Remodelación Ventricular , Adulto , Índice de Masa Corporal , Enfermedades Cardiovasculares/complicaciones , Grosor Intima-Media Carotídeo , Estudios de Casos y Controles , Análisis Mutacional de ADN , Ecocardiografía , Enfermedad de Fabry/complicaciones , Femenino , Heterocigoto , Humanos , Hipertrofia Ventricular Izquierda/diagnóstico , Masculino , Microcirculación , Angioscopía Microscópica , Persona de Mediana Edad , Mutación , Riesgo , Ultrasonografía
13.
Healthcare (Basel) ; 12(4)2024 Feb 19.
Artículo en Inglés | MEDLINE | ID: mdl-38391875

RESUMEN

Superficial venous thrombosis (SVT), an inflammatory-thrombotic process of a superficial vein, is a relatively common event that may have several different underlying causes. This phenomenon has been generally considered benign, and its prevalence has been historically underestimated; the estimated incidence ranges from about 0.3 to 1.5 event per 1000 person-years, while the prevalence is approximately 3 to 11%, with different reports depending on the population studied. However, such pathology is not free of complications; indeed, it could extend to the deep circulation and embolize to pulmonary circulation. For this reason, an ultrasound examination is recommended to evaluate the extension of SVT and to exclude the involvement of deep circulation. Also, SVT may be costly, especially in the case of recurrence. Therefore, accurate management is necessary to prevent sequelae and costs related to the disease. This review aims to analyse the epidemiology of SVT, its complications, optimal medical treatment, and open questions with future perspectives.

14.
J Clin Med ; 13(8)2024 04 19.
Artículo en Inglés | MEDLINE | ID: mdl-38673665

RESUMEN

Background: Anticoagulation for venous thromboembolism (VTE) is required for at least three to six months; however, it is advisable to extend the duration in certain cases, in which case a reduced dose of Direct Oral Anticoagulants (DOACs) may be an option. Our objective was to investigate the efficacy and safety of reduced-dose DOACs in extended anticoagulation treatment compared to full doses. Methods and Results: This retrospective single-centre study included 185 patients treated with DOACs for at least 6 months who were divided into two groups: (1) the Full Dose (FD) group (n = 113) and (2) the Reduced Dose (RD) group (n = 72), which included patients treated with Apixaban at 2.5 mg bis in die (BID) and Rivaroxaban at 10 mg once daily (OD). Post-thrombotic syndrome (PTS) and its progression were evaluated. During an overall follow-up of 48.32 ± 29.49 months, no VTE occurred, and no patients experienced major bleeding; clinically relevant non-major bleeding occurred in three patients in each group (2.7% vs. 4.2% in FD vs. RD, respectively, p = 0.57). From baseline to follow-up, the prevalence of PTS was not significantly decreased in either group (FD: 54.9% vs. 51.3%, p = 0.29; RD 51.4% vs. 44.4%, p = 0.12); conversely, the Villalta score values were significantly decreased at the last follow-up (FD: 5.51 ± 4.18 vs. 5.12 ± 4.36, p < 0.001; RD 5.49 ± 4.06 vs. 5.11 ± 3.73, p = 0.006). Conclusion: In this real-world retrospective registry, very long-term extended anticoagulant therapy with DOACs at full or reduced doses showed comparable efficacy, safety, and impact on PTS progression. Larger studies are needed.

15.
Genes (Basel) ; 15(8)2024 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-39202460

RESUMEN

Anderson-Fabry disease (AFD) is a genetic lysosomal storage disorder caused by mutations in the α-galactosidase A gene, leading to impaired lysosomal function and resulting in both macrovascular and microvascular alterations. AFD patients often exhibit increased intima-media thickness (IMT) and reduced flow-mediated dilation (FMD), indicating non-atherosclerotic arterial thickening and the potential for cardiovascular events. Nailfold capillaroscopy, a non-invasive diagnostic tool, has shown potential in diagnosing and monitoring microcirculatory disorders in AFD, despite limited research. This study evaluates nailfold capillaroscopy findings in AFD patients, exploring correlations with GLA gene variant subgroups (associated with classical or late-onset phenotypes and variants of uncertain significance (VUSs)), and assessing morpho-functional differences between sexes. It aims to determine whether capillaroscopy can assist in the early identification of individuals with multiorgan vascular involvement. A retrospective observational study was conducted with 25 AFD patients from AOUP "G. Rodolico-San Marco" in Catania (2020-2023). Patients underwent genetic testing, enzyme activity evaluation, and nailfold capillaroscopy using Horus basic HS 200 videodermatoscopy. Parameters like angiotectonic disorder, vascular areas, capillary density, and intimal thickening were assessed. The study identified significant differences in capillaroscopy findings among patients with different GLA gene variant subgroups. Classic AFD variant patients showed reduced capillary length and signs of erythrocyte aggregation and dilated subpapillary plexus. No correlation was found between enzymatic activity and capillaroscopy parameters. However, Lyso-Gb3 levels were positively correlated with average capillary length (ῤ = 0.453; p = 0.059). Sex-specific differences in capillaroscopy findings were observed in neoangiogenesis and average capillary length, with distinct implications for men and women. This study highlights the potential of nailfold capillaroscopy in the diagnostic process and clinical management of AFD, particularly in relation to specific GLA gene mutations, as a valuable tool for the early diagnosis and monitoring of AFD.


Asunto(s)
Enfermedad de Fabry , Angioscopía Microscópica , Humanos , Enfermedad de Fabry/genética , Enfermedad de Fabry/patología , Enfermedad de Fabry/diagnóstico por imagen , Masculino , Femenino , Angioscopía Microscópica/métodos , Adulto , Persona de Mediana Edad , alfa-Galactosidasa/genética , Estudios Retrospectivos , Mutación , Anciano
16.
Catheter Cardiovasc Interv ; 79(1): 30-40, 2012 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-21956876

RESUMEN

BACKGROUND: Although the advancement of the equipment and the presence of innovative techniques, percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) continues to be affected by lower procedural success in comparison with non occluded vessel PCI. OBJECTIVE: We describe a new technique for the treatment of coronary CTO which utilizes a new generation of polymeric wires. METHODS AND RESULT: From March 2009 to June 2010 different strategies were adopted as "bail out" after an initial attempt failed in 117 consecutive CTO lesions. Among these, conventional strategies (CS) such as parallel wire, sub-intimal tracking and re-entry (STAR), microchannel technique, intracoronary ultrasound guided revascularization and anchor balloon, were used in 75 cases (64.1%), while in the remaining a new technique, the "mini-STAR," was used (39.9%). Although no substantial differences were observed regarding the distribution of clinical features and angiographic lesions characteristics between the populations, mini-STAR was able to achieve a higher rate of procedural success in comparison with other CS (97.6% vs. 52%, P < 0.001) with lower contrast agent use (442 ± 259 cm(3) vs. 561 ± 243 cm(3), P = 0.01) and shorter procedural and fluoroscopy times (122 ± 61 vs. 157 ± 74 min, P = 0.009 and 60 ± 31 min vs. 75 ± 38 min, P = 0.03, respectively). No differences were observed in term of peri-procedural complications such as procedural myocardial infarction, coronary perforations, and contrast-induced nephropathy between mini-STAR and CS. CONCLUSION: The mini-STAR technique is a promising strategy for the treatment of CTO lesions, achieving a high procedural success rate and low occurrence of procedural adverse events.


Asunto(s)
Angioplastia Coronaria con Balón/métodos , Oclusión Coronaria/terapia , Anciano , Angioplastia Coronaria con Balón/efectos adversos , Angioplastia Coronaria con Balón/instrumentación , Angioplastia Coronaria con Balón/mortalidad , Catéteres , Enfermedad Crónica , Angiografía Coronaria , Oclusión Coronaria/diagnóstico por imagen , Oclusión Coronaria/mortalidad , Vasos Coronarios/lesiones , Stents Liberadores de Fármacos , Diseño de Equipo , Femenino , Lesiones Cardíacas/etiología , Humanos , Italia , Masculino , Persona de Mediana Edad , Infarto del Miocardio/etiología , Diseño de Prótesis , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento
17.
J Clin Med ; 11(13)2022 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-35807107

RESUMEN

In the last two years, the new coronavirus has afflicted the whole world causing a pandemic burdened by high morbidity and mortality [...].

18.
J Clin Med ; 11(11)2022 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-35683485

RESUMEN

Coronavirus disease 2019 (COVID-19) is associated with an increased risk of venous thromboembolism (VTE) and coagulopathy, especially in critically ill patients. Endothelial damage induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is emerging as a crucial pathogenetic mechanism for the development of complications in an acute phase of the illness and for several postdischarge sequalae. Heparin has been shown to have a positive impact on COVID-19 due to its anticoagulant function. Moreover, several other biological actions of heparin were postulated: a potential anti-inflammatory and antiviral effect through the main protease (Mpro) and heparansulfate (HS) binding and a protection from the damage of vascular endothelial cells. In this paper, we reviewed available evidence on heparin treatment in COVID-19 acute illness and chronic sequalae, focusing on the difference between prophylactic and therapeutic dosage.

19.
J Interv Cardiol ; 24(5): 426-36, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22004600

RESUMEN

BACKGROUND: Drug-eluting stents showed a better angiographic and clinical outcome in comparison with bare metal stent in chronic total occlusions (CTOs) percutaneous revascularization, however, great concerns still remain regarding the rate of restenosis and reocclusion in comparison with nonocclusive lesions. AIM: To evaluate angiographic and clinical outcomes after sirolimus-eluting stent (SES) implantation in the setting of a "real world" series of complex CTOs. METHODS AND RESULTS: From January 2006 to December 2008, 172 consecutive patients with 179 CTO lesions were enrolled into registry. Among these, successful recanalization was obtained in 144 lesions (80.4%) with exclusive SES implantation in 104 lesions. The 9-12 months angiographic follow-up was executed in 85.5% of lesions with evidence of angiographic binary restenosis in 16.8% of lesions. Total stent length and number of stent implanted were recognized as independent predictors of restenosis (odds ratio [OR] 4.7, 95% confidence interval [CI] 1.28-107.09, P = 0.02) and (OR 5.8, 95% CI 1.39-23.55, P = 0.01), respectively.The 2-year clinical follow-up showed rates of target lesion revascularization, non-Q wave myocardial infarction, and total major adverse cardiovascular events (MACEs) of 11.1%, 2%, and 13.1%, respectively. Cox proportional-hazard analysis showed diabetes as independent predictor of MACEs (hazard ratio [HR] 4.832; 95% CI, 0.730-0.861; P = 0.028). CONCLUSIONS: Data from this registry demonstrate the long-term efficacy and safety of SES implantation after complex CTOs recanalization.


Asunto(s)
Angioplastia Coronaria con Balón , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/terapia , Reestenosis Coronaria/prevención & control , Stents Liberadores de Fármacos , Anticoagulantes/uso terapéutico , Intervalos de Confianza , Enfermedad de la Arteria Coronaria/tratamiento farmacológico , Femenino , Heparina/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Estudios Prospectivos , Sistema de Registros , Medición de Riesgo , Sirolimus/uso terapéutico , Factores de Tiempo , Resultado del Tratamiento
20.
J Interv Cardiol ; 24(3): 223-31, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21309854

RESUMEN

BACKGROUND: Previous studies have reported that the indeterminable aging and long-duration occlusion are associated with procedural failure and adverse long-term outcome. We aimed to investigate the clinical impact of occlusion duration in a consecutive series of patients who underwent percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) lesions. METHODS AND RESULTS: From October 2005 to June 2009, a total of 303 patients with 328 CTO lesions were consecutively treated achieving a success rate of 86.3%. The average of occlusion duration estimated in 62.5% of cases (known occlusion duration [KOD] patients, n = 188) was 29.8 ± 41.3 months. In the remaining 37.5% of cases, the occlusion duration was indeterminate (indetermination of occlusion duration [IOD] patients, n = 115). No influence of duration in procedural outcome was observed. Moreover, no differences of 1-year major adverse cardiac events (MACE) were observed between KOD and IOD patients. The multivariate COX regression analysis identified diabetes mellitus and multivessel coronary disease as independent predictors of 12-month MACE (HR 5.023; 95% CI 0.164-9.653; P = 0.025 and HR 0.801; 95% CI 0.109-0.909, P = 0.033). The analysis did not show any influence of IOD and long occlusion duration in the occurrence of MACE. Predictors of angiographic failure recognized with multivariate binary logistic were vessel diameter <2.5 mm (OR 5.3; 95% CI 1.19-8.91; P = 0.02), CTO length >20 mm (OR 6.3; 95% CI 1.22-9.54; P = 0.02), and severe calcification (OR 3.2; 95% CI 1.62-5.51; P = 0.03). CONCLUSION: IOD and long duration of CTO do not affect procedural and clinical outcome of patients who underwent CTO PCI. This marks the importance of considering PCI treatment, a reliable strategy in cases of IOD or long occlusion duration.


Asunto(s)
Angioplastia Coronaria con Balón , Oclusión Coronaria/terapia , Anciano , Enfermedad Crónica , Angiografía Coronaria , Oclusión Coronaria/complicaciones , Oclusión Coronaria/diagnóstico por imagen , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA